Bladder cancer: Difference between revisions

no edit summary
No edit summary
No edit summary
Line 60: Line 60:


Non-muscle invasive and muscle-invasive disease can only be distinguished by transurethral resection of the bladder or by MRi. CT cannot distinguish them.
Non-muscle invasive and muscle-invasive disease can only be distinguished by transurethral resection of the bladder or by MRi. CT cannot distinguish them.
<section end="radiology" />
<section end="radiology" /><section end="urology" /><section begin="urology treatment" />
== Management ==
== Management ==
Management for non-metastatic disease (stages I - III) involves either cystoscopic surgical removal of the tumour (TUR-B), complete surgical removal of the bladder (radical cystectomy), or radiotherapy + chemotherapy. For metastatic disease, only chemotherapy and/or immunotherapy is indicated.
Management for non-metastatic disease (stages I - III) involves either cystoscopic surgical removal of the tumour (TUR-B), complete surgical removal of the bladder (radical cystectomy), or radiotherapy + chemotherapy. For metastatic disease, only chemotherapy and/or immunotherapy is indicated.
Line 90: Line 90:


=== Radiotherapy ===
=== Radiotherapy ===
Radiotherapy may be part of bladder preservation therapy or be used palliatively for metastatic disease.<section end="oncology" /><section end="urology" />
Radiotherapy may be part of bladder preservation therapy or be used palliatively for metastatic disease.<section end="oncology" /><section end="urology treatment" />
[[Category:Urology]]
[[Category:Urology]]
[[Category:Oncology]]
[[Category:Oncology]]